BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20963909)

  • 1. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():803-6. PubMed ID: 20963909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
    Okamoto T
    Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
    Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
    Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New endocrine tumor markers of gynecologic malignancies. A review.
    Kauppila A; Santala M
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):833-7. PubMed ID: 10577610
    [No Abstract]   [Full Text] [Related]  

  • 12. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O; Halim AB; Gad M; Walker R
    Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
    Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary gonadotropin peptide in patients with cancer of digestive organs.
    Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N
    Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [false-positive results of human chorionic gonadotropin β measurement after high orchiectomy for stage i seminoma: report of a case].
    Tomita K; Nishikawa N; Takimoto K; Kim CJ
    Hinyokika Kiyo; 2010 Nov; 56(11):663-5. PubMed ID: 21187715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the hCGβcf in urine during pregnancy.
    Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
    Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
    Schutter EM; Mulder C; van Kamp GJ; Kenemans P
    Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the glycoforms of human chorionic gonadotropin beta-core fragment by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Jacoby ES; Kicman AT; Laidler P; Iles RK
    Clin Chem; 2000 Nov; 46(11):1796-803. PubMed ID: 11067815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin.
    Shih IM; Torrance C; Sokoll LJ; Chan DW; Kinzler KW; Vogelstein B
    Nat Med; 2000 Jun; 6(6):711-4. PubMed ID: 10835692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.